FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

cobas Influenza A/B & RSV Nucleic acid test for use on the cobas Liat System

K Number: K210234 · Decision Feb 16, 2021
Classifications
1
FEI Numbers
29
Registration Numbers
29
Same Product Code
77
Applicant Total
28
Review Days
19

Basic Information

Device Name
cobas Influenza A/B & RSV Nucleic acid test for use on the cobas Liat System
K Number
K210234
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
866.3980
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Roche Molecular Systems, Inc.
Date Received
January 28, 2021
Decision Date
February 16, 2021
Product Code
OCC
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OCC Respiratory Virus Panel Nucleic Acid Assay System

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (OCC), ordered by most recent decision date.

View all

Other Clearances by Roche Molecular Systems, Inc.

K Number Device Name
K243863 Opulus™ Lymphoma Precision
K243406 cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test
K243400 cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test
K243346 cobas liat SARS-CoV-2 v2 nucleic acid test
K240867 cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems
K240217 cobas® liat CT/NG nucleic acid test
K240197 cobas® liat CT/NG/MG nucleic acid test
K223783 cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System
K223591 cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System
K231306 cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems
Search all 28 clearances from Roche Molecular Systems, Inc. →